Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve unaudited financial results for the ...

Read also: Zydus Lifscience Gets CDSCO Panel Nod To study Anti-cancer Drug Pertuzumab He has demonstrated capabilities in judicious deployment of resources to achieve maximum operational efficiency.

Zydus Wellness Ltd share price was up by 1.60% from the previous closing price of ₹1,976.05. Who are peers of Zydus Wellness Ltd? The peers of Zydus Wellness Ltd are Hindustan Unilever Ltd ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Zydus Wellness Limited is an India-based consumer company. The Company is focused on providing health and wellness-oriented products across two primary segments: Food & Nutrition and Personal Care ...

Ahmedabad: Zydus Wellness Products Limited, a wholly owned subsidiary of Zydus Wellness, has received a GST demand of Rs 56.33 crores along with applicable interest and penalty from the tax authority.

Zydus Wellness Ltd announced that its subsidiary, Zydus Wellness Products Ltd, has received a GST demand of Rs 56.33 crore with interest and penalties from the tax authority. The demand relates to ...

Saroglitazar is under clinical development by Zydus Therapeutics and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to GlobalData, Phase II drugs for ...

Roche has secured EU approval for Phesgo, a fixed-dose combination of its breast cancer drugs Herceptin and Perjeta that is easier and cheaper to administer to patients – and also provides a ...